SAB Biotherapeutics (SABS) has provided an announcement.
The Company has announced the appointment of Ms. To through a press release, stressing that the information provided is for informational purposes only and not for legal use within the context of the Securities Exchange Act of 1934. This appointment news is not intended for formal financial documentation or to influence any liabilities under the Act.
See more data about SABS stock on TipRanks’ Stock Analysis page.